Advertisement

Topics

Latest "Placebo Hepatitis Virus Infection" News Stories

22:34 EST 11th February 2016 | BioPortfolio

Here are the most relevant search results for "Placebo Hepatitis Virus Infection" found in our extensive news archives from over 250 global news sources.

More Information about Placebo Hepatitis Virus Infection on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Placebo Hepatitis Virus Infection for you to read. Along with our medical data and news we also list Placebo Hepatitis Virus Infection Clinical Trials, which are updated daily. BioPortfolio also has a large database of Placebo Hepatitis Virus Infection Companies for you to search.

Showing "Placebo Hepatitis Virus Infection" News Articles 1–25 of 7,600+

Extremely Relevant

Screening and Prevention of Hepatitis B Virus Reactivation During Chemotherapy

The incidence of both hepatitis B virus infection and cancer is common. The use of immunosuppressive therapy in patients with hepatitis B virus can result in reactivation of hepatitis B virus, which can, in turn, lead to significant morbidity and mortality.


Seals Harbor Hepatitis A-Like Virus

Scientists in the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A. The research appears in the July/August issue of mBio, the online open-access journal of the American Society for Microbi...

Baraclude safely reduces HBV DNA among children, adolescents

In a randomized phase 3 study, children and adolescents with chronic hepatitis B virus infection treated with Baraclude showed reduced infection compared with children treated with placebo, according to published findings. Researchers randomly assigned 180 treatment-naive children and adolescents to a regimen of Baraclude (entecavir, Bristol-Myers Squibb; n = 120) or placebo (n = 60) for a duratio...


Hepatitis C Linked to Increased Risk of Parkinson’s

People infected with the hepatitis C virus may have an increased risk of developing Parkinson’s disease, according to a new study out of Taiwan.  Hepatitis C is a liver infection caused by a virus. Between 130 million and 150 million people worldwide have chronic hepatitis C infection, according to the World Health Organization.

CDC Urges Dialysis Providers to Improve Infection Control to Stop Hepatitis C Virus Transmission

The Centers for Disease Control and Prevention (CDC) has received an increased number of reports of newly acquired hepatitis C virus (HCV) infection among patients undergoing hemodialysis. Infection control lapses in dialysis care could expose patients to HCV. Any case of new HCV infection in a patient undergoing hemodialysis should prompt

Management of chronic hepatitis B infection

Hepatitis B virus (HBV) is a global health problem that can lead to cirrhosis and hepatocellular carcinoma (HCC). Although HBV vaccination has reduced the prevalence Of HBV infection, the burden of...

Hepatitis A-like virus identified in seals

(American Society for Microbiology) Scientists in the Center for Infection and Immunity at the Mailman School of Public Health have discovered a new virus in seals that is the closest known relative of the human hepatitis A virus. The finding provides new clues on the emergence of hepatitis A. The research appears in the July/August issue of mBio, the online open-access journal of the American Soc...

MMWR: Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex with Men --- New York City, 2005--2010

In the United States, an estimated 3.2 million persons are living with hepatitis C virus (HCV) infection. HCV transmission occurs primarily through percutaneous exposure to blood, and persons who inject drugs are at greatest risk for infection. The role of sexual transmission of HCV has not been well defined. However, reports over the past decade, mainly from Europe, have implicated sexual tra...

Expression of a Single Gene Lets Scientists Grow Hepatitis C Virus in the Lab

Worldwide, 185 million people have chronic hepatitis C. Since the late 1980s, when scientists discovered the virus that causes the infection, they have struggled to find ways to grow it in human cells in the lab -- an essential part of learning how the virus works and developing new effective treatments. In a study published in Nature on August

Chronic kidney disease: Treatment of hepatitis C virus infection in patients with CKD

Treatment of hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) can be challenging. Now, data from the phase III C-SURFER study show that grazoprevir and elbasvir — a new all-oral combination therapy for HCV — is safe and effective in patients with stage 4–5 CKD.

Natural Immunity May Lead Fight Against Hepatitis C Virus, Liver Disease

University of Adelaide researchers have uncovered the role played by a family of genes, which can suppress hepatitis C virus (HCV) infection within the liver. The findings, published in the Journal of Biological Chemistry, shed light on the activity of these genes and how they produce a natural immune response to the virus. HCV is a major health

Slide Show: Healthcare-Associated Hepatitis B and C Outbreaks

This slide show summarizes healthcare-associated outbreaks of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in the United States during 2008-2014, as reported to the CDC.

Hepatitis C Tied to Increase Risk of Parkinson's

The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the December 23, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. Parkinson's disease is considered the second most common degenerative brain disorder after Alzheimer's disease. Hepatitis C is a liver infection caused by a vi...

NICE recommends BMS's daklinza to treat hepatitis C virus

The UK's National Institute for Health and Care Excellence (NICE) has recommended Bristol-Myers Squibb's (BMS) daklinza (daclatasvir) to treat adults with chronic hepatitis C virus (HCV) infection in England and Wales.

Zepatier Approved for Chronic Hepatitis C

FRIDAY, Jan. 29, 2016 -- Zepatier (a combination of elbasavir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic infection with the hepatitis C virus, genotypes 1 and 4. Hepatitis C causes liver...

Hepatitis C infection may fuel heart risk

(Johns Hopkins Medicine) People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble.

Hepatitis C Positive Antibody Test Leads to Molecular Assay

Conventional laboratory and medical practice for Hepatitis C virus infection involves referring a patient for a second office visit and blood draw...

New virus identified in blood supply

Scientists have discovered a new virus that can be transmitted through the blood supply. Currently, it is unclear whether the virus is harmful or not, but it is related to hepatitis C virus (HCV) and human pegivirus (HPgV), the latter of which was formerly known as hepatitis G virus. The new virus, which researchers have named human hepegivirus-1 (HHpgV-1), is described in the September 22 issue o...

One-step test for hepatitis C virus infection

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the Annual Meeting of American Association for the Study of Liver Disease (AASLD) in San Francisco, Nov. 14-16. Current blood-based HCV testing requires two […]

A New Era of Therapy for Hepatitis C Virus Infection

IFN-free regimens with direct-acting antivirals have quickly become the mainstay of treatment for HCV infection. Read more about them here. Current Opinion in Infectious Diseases

The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA

In this Review, Lemon and colleagues describe the interactions of the RNA genome of hepatitis C virus with various host proteins and microRNAs. They discuss how these interactions affect viral RNA synthesis and decay, and how they influence the long-term persistence of the virus.

Hepatitis C tied to increased risk of Parkinson's

(American Academy of Neurology) The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the Dec. 23, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology. Parkinson's disease is considered the second most common degenerative brain disorder after Alzheimer's disease. Hepatitis C is a l...

More Hepatitis C Cases Being Seen in Urban ERs

FRIDAY, Aug. 7, 2015 -- New research reveals high rates of hepatitis C infection among intravenous drug users and baby boomers seen in urban emergency departments. And three-quarters of those who tested positive for the potentially deadly virus did...

Updated Fact Sheet: HIV and Viral Hepatitis

This fact sheet discusses coinfection of HIV and Viral Hepatitis. People with HIV infection are disproportionally affected by viral hepatitis. About 80% of people with HIV who inject drugs also have hepatitis C virus (HCV). HIV coinfection more than triples the risk for liver disease, liver failure, and liver-related death from HCV.

Migration contributes to flat HBV infection prevalence rate in US

(HealthDay)—The prevalence of chronic hepatitis B virus (HBV) infection has remained constant since 1999, according to a study published online Aug. 6 in Hepatology.


Quick Search
Advertisement
 

News Quicklinks